Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-036534

Chief Business Officer sold 23,401 shares at an average $26.27 ($614,788)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Robb Gary Charles Chief Business Officer 2022-11-17 Sale −10,000 $26.06 $260,600 39,544 D
Robb Gary Charles Chief Business Officer 2022-11-18 Sale −13,401 $26.43 $354,188 26,143 D
Open-market sales · 23,401 sh · avg $26.27 · $614,788
Loading xslF345X03/doc4.xml…